Intravenous enzyme replacement therapy: better in home or hospital?
Authors:
- Derralynn HughesDHDerralynn Hughes
- Sian GoodwinSGSian Goodwin
- Linda RichfieldLRLinda Richfield
- 23 March 2006
- journal article
- research article
- Published by Mark Allen Group in British Journal of Nursing
- Vol. 15 (6) , 330-333
Abstract
This article evaluates satisfaction with enzyme replacement therapy (ERT) at home and at hospital in adult patients with Fabry and Gaucher diseases. A questionnaire was developed and sent to 34 patients with Fabry disease who were receiving ERT with agalsidase alfa (Replagal™) and to 49 patients with type I Gaucher disease who were receiving ERT with glucocerebrosidase (Cerezyme®). Of the 45 returned questionnaires, 20 were from patients with Fabry disease and 25 from patients with Gaucher disease. Hospital treatment visits were reported as stressful by 18 patients (40%), whereas only 4 (9%) patients reported that home therapy was stressful. Both groups of patients adjusted well to receiving home-based therapy. Nearly all of the patients with Fabry disease (19 patients, 95%) and Gaucher disease (21 patients, 84%) preferred home-based therapy. Treatment in the home was reported as more comfortable, less stressful, more effective and had less impact on family life. Only 4 (9%) patients chose to continue receiving infusions in hospital. The majority of patients with Fabry disease and Gaucher disease found home-based therapy to be more convenient and less stressful than hospital-based therapy.Keywords
This publication has 16 references indexed in Scilit:
- Gaucher disease: pathological mechanisms and modern managementBritish Journal of Haematology, 2005
- New developments in the management of Anderson-Fabry diseaseQJM: An International Journal of Medicine, 2002
- Advances in the management of Anderson–Fabry disease:enzyme replacement therapyExpert Opinion on Biological Therapy, 2002
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier femalesJournal of Medical Genetics, 2001
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous malesJournal of Medical Genetics, 2001
- The Gaucher RegistryArchives of internal medicine (1960), 2000
- Prevalence of Lysosomal Storage DisordersJAMA, 1999
- Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 monthsBlood, 1993
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher's diseaseBiochemical and Biophysical Research Communications, 1965